tiprankstipranks
Trending News
More News >
Aspen Pharmacare (APNHY)
OTHER OTC:APNHY

Aspen Pharmacare (APNHY) Price & Analysis

Compare
22 Followers

APNHY Stock Chart & Stats

$6.80
$0.00(0.00%)
At close: 4:00 PM EST
$6.80
$0.00(0.00%)

APNHY FAQ

What was Aspen Pharmacare’s price range in the past 12 months?
Aspen Pharmacare lowest stock price was $5.24 and its highest was $10.05 in the past 12 months.
    What is Aspen Pharmacare’s market cap?
    Aspen Pharmacare’s market cap is $3.17B.
      When is Aspen Pharmacare’s upcoming earnings report date?
      Aspen Pharmacare’s upcoming earnings report date is Mar 03, 2026 which is in 51 days.
        How were Aspen Pharmacare’s earnings last quarter?
        Aspen Pharmacare released its earnings results on Sep 03, 2025. The company reported -$0.425 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.425.
          Is Aspen Pharmacare overvalued?
          According to Wall Street analysts Aspen Pharmacare’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Aspen Pharmacare pay dividends?
            Aspen Pharmacare pays a Annually dividend of $0.122 which represents an annual dividend yield of 2.15%. See more information on Aspen Pharmacare dividends here
              What is Aspen Pharmacare’s EPS estimate?
              Aspen Pharmacare’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does Aspen Pharmacare have?
              Aspen Pharmacare has 446,252,320 shares outstanding.
                What happened to Aspen Pharmacare’s price movement after its last earnings report?
                Aspen Pharmacare reported an EPS of -$0.425 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.217%.
                  Which hedge fund is a major shareholder of Aspen Pharmacare?
                  Currently, no hedge funds are holding shares in APNHY
                  What is the TipRanks Smart Score and how is it calculated?
                  Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                    Aspen Pharmacare Stock Smart Score

                    3
                    Underperform
                    1
                    2
                    3
                    4
                    5
                    6
                    7
                    8
                    9
                    10

                    Technicals

                    SMA
                    Negative
                    20 days / 200 days
                    Momentum
                    -45.29%
                    12-Months-Change

                    Fundamentals

                    Return on Equity
                    -1.18%
                    Trailing 12-Months
                    Asset Growth
                    0.34%
                    Trailing 12-Months

                    Company Description

                    Aspen Pharmacare

                    Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anesthetics, muscle relaxants, and topical agents under the Anaesthetics brand; and a range of injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand. It also offers branded consumer, prescription, and over-the-counter products under the regional brands, such as Circadin, Foxair, Maltofer, Mybulen, and Zyloric for various types of anesthetic comprises sleeping aid, respiratory, iron supplement, analgesic, and uric acid production inhibitor. In addition, the company manufactures and sells active pharmaceutical ingredients and finished dose form products to third-party customers. The company was founded in 1850 and is headquartered in Durban, South Africa.

                    Aspen Pharmacare (APNHY) Earnings & Revenues

                    APNHY Company Deck

                    APNHY Earnings Call

                    Q4 2025
                    0:00 / 0:00
                    Earnings Call Sentiment|Neutral
                    The earnings call highlighted strong growth in the Commercial Pharma segment and successful product launches, particularly in emerging markets. However, the loss of a key contract, adverse currency impacts, increased tax burdens, and challenges in the Manufacturing segment notably affected the overall financial performance.View all APNHY earnings summaries
                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    Perrigo Company
                    Supernus Pharmaceuticals
                    HUTCHMED
                    Amneal Pharmaceuticals
                    Alvotech

                    Ownership Overview

                    <0.01%<0.01%99.99%
                    Insiders
                    <0.01% Other Institutional Investors
                    99.99% Public Companies and
                    Individual Investors

                    Options Prices

                    Currently, No data available
                    ---
                    Popular Stocks